Cart
Orders
Not available here
Product Overview
SAVE B32SP is an HA skin booster from ARUDA Co., Ltd., manufactured in South Korea. Its manufacturer-listed composition combines high- and low-molecular-weight hyaluronic acid with succinic acid and Copper Tripeptide-1 in a 2.5 mL single-syringe format. For professional buyers comparing formulations, the documented amounts are 40 mg of each HA fraction and 40 mg of succinic acid per syringe. The specifications below describe SAVE B32SP specifically.
Key Features
- Two HA fractions: High- and low-molecular-weight hyaluronic acid contribute 80 mg of total HA per 2.5 mL syringe.
- Additional distinguishing ingredients: The manufacturer lists succinic acid and Copper Tripeptide-1 alongside HA.
- Single-syringe presentation: The documented package format is 2.5 mL × 1 syringe.
Composition & Specifications
| Specification | Details |
|---|---|
| Product name | SAVE B32SP |
| Product category | Manufacturer-described HA skin booster |
| Manufacturer | ARUDA Co., Ltd. |
| Country of origin | South Korea |
| High-molecular-weight hyaluronic acid | 40 mg per 2.5 mL syringe |
| Low-molecular-weight hyaluronic acid | 40 mg per 2.5 mL syringe |
| Total hyaluronic acid | 80 mg per 2.5 mL syringe; combined concentration 32 mg/mL |
| Succinic acid | 40 mg per 2.5 mL syringe |
| Peptide | Copper Tripeptide-1 |
| Package format | 2.5 mL × 1 syringe |
This is a summary of the manufacturer-listed distinguishing ingredients, not a complete ingredient declaration. Ingredient amounts describe syringe contents, not administration recommendations.
Frequently Asked Questions
Does 32 mg/mL refer to each HA fraction?
No. The 32 mg/mL value describes the combined HA concentration. SAVE B32SP contains 40 mg of high-molecular-weight HA and 40 mg of low-molecular-weight HA in a 2.5 mL syringe.
What should professional buyers confirm for the supplied market version?
Check the current package labeling and instructions for use for the full ingredient declaration, lidocaine status, accessories, storage conditions and expiry date. Confirm the applicable intended use and local supply requirements before procurement; the skin-booster category is not a statement of regulatory authorization.